Ads
related to: fda s- Contact Us
Call + Email
24/7 Live Chat
- Verify: FDA Registration
Free Tool To Verify That Your US
FDA Registration Is Currently Valid
- FDA Registration
Quick & Easy
Register Your Business
- Food & Beverage
Full Service
Everything You Need
- Contact Us
Search results
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 7 hours ago, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some...
FDA allows Neuralink to implant 2nd patient with brain chip
FOX 10 Phoenix· 2 hours agoThe Food and Drug Administration has approved Neuralink to implant its brain chip into a second...
LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements | JD Supra
JD Supra· 14 hours agoOn May 6, 2024, the U.S. Food and Drug Administration (FDA) issued its final rule significantly modifying FDA’s approach ...
Larimar's Friedreich's ataxia program free at last from FDA hold
FierceBiotech· 8 hours agoLarimar Therapeutics’ Friedreich’s ataxia program is free at last, with the FDA fully lifting a...
FDA seeks AI tech to predict, detect Parkinson’s symptoms
MedTech Dive via Yahoo Finance· 10 hours agoBy testing artificial intelligence and machine learning models, the agency hopes to come up with...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
AOL· 8 hours agoThe reviewers, however, said a benefit would be that the test may increase compliance with screening for colorectal cancer and detect it in earlier stages, potentially helping cure patients ...
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
NBC 17 Raleigh· 14 hours agoKS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo ...
FDA Approves Boehringer Ingelheim’s CYLTEZO® Biosimilar to Humira for Multiple Chronic Inflammatory...
JD Supra· 14 hours agoCYLTEZO was first approved in the US in 2017 and later approved in the US as an interchangeable biosimilar to Humira in October 2021. A lower concentration version of CYLTEZO (50 mg/mL) has been on the market since July 2023.
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 13 hours agoAdministered intravitreally into the eye as a 2mg injectable solution, Yesafili and Opuviz follow...
US FDA staff says Guardant’s test may fail to detect some pre-cancerous tumors
WSAU Wausau· 7 hours ago(Reuters) -The U.S. Food and Drug Administration's staff reviewers on Tuesday raised concerns that...